Medical Foods For Orphan Diseases Market

Oral administration is expected to account for 68.0% share in 2026, powder represents 42.0% by product type, institutional sales hold 38.0% of distribution channel. Lifelong supervised nutrition supports repeat use following confirmed diagnosis, but taste fatigue and uneven reimbursement can interrupt continued access.